Sutro Biopharma

Biopharmaceuticals

Sutro Biopharma is a biopharmaceutical company that uses its patented OCFS protein synthesis technology to develop next-generation protein therapeutics for the treatment of human disease. Sutro is applying its technology to the development of...

Founded in 2003
Homepage: http://www.sutrobio.com/
Total money raised: $90.3M

HQ

94080 310 Utah Ave
Suite 150
South San Francisco
USA CA

Phone: 650.392.8412

Updated on Mar 24, 2013
Sutro Biopharma at CrunchBase

Michael Ross Board Director
Past

May, 2012

Sutro Biopharma raised $16.5M in a Series C round from Skyline Ventures, Lilly Ventures, Amgen Ventures, SV Life Sciences, and Alta Partners

Sutro Closes $16.5 Million Second Tranche of Series C Financing

finance.yahoo.com

November, 2010

Sutro Biopharma raised $36.5M in a Series C round from Skyline Ventures, Lilly Ventures, Amgen Ventures, SV Life Sciences, and Alta Partners

Sutro Biopharma Secures $36.5M in Series C Financing

March, 2009

Sutro Biopharma raised $15M in a Series B round from Alta Partners and SV Life Sciences

Sutro Biopharma lands $15M with protein production

bizjournals.com

December, 2007

Sutro Biopharma raised $21M in a Series B round from SV Life Sciences and Alta Partners

Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer

October, 2007

Sutro Biopharma raised $305K in unattributed round from SV Life Sciences and International Biotechnology Trust

January, 2006

Sutro Biopharma raised $1M in a Series A round from SV Life Sciences

2003

Sutro Biopharma was founded in 2003